Статті в журналах з теми "Drug-tolerant Mtb"
Оформте джерело за APA, MLA, Chicago, Harvard та іншими стилями
Ознайомтеся з топ-28 статей у журналах для дослідження на тему "Drug-tolerant Mtb".
Біля кожної праці в переліку літератури доступна кнопка «Додати до бібліографії». Скористайтеся нею – і ми автоматично оформимо бібліографічне посилання на обрану працю в потрібному вам стилі цитування: APA, MLA, «Гарвард», «Чикаго», «Ванкувер» тощо.
Також ви можете завантажити повний текст наукової публікації у форматі «.pdf» та прочитати онлайн анотацію до роботи, якщо відповідні параметри наявні в метаданих.
Переглядайте статті в журналах для різних дисциплін та оформлюйте правильно вашу бібліографію.
Mishra, Richa, Sakshi Kohli, Nitish Malhotra, Parijat Bandyopadhyay, Mansi Mehta, MohamedHusen Munshi, Vasista Adiga, et al. "Targeting redox heterogeneity to counteract drug tolerance in replicating Mycobacterium tuberculosis." Science Translational Medicine 11, no. 518 (November 13, 2019): eaaw6635. http://dx.doi.org/10.1126/scitranslmed.aaw6635.
Повний текст джерелаVilchèze, Catherine, Travis Hartman, Brian Weinrick, Paras Jain, Torin R. Weisbrod, Lawrence W. Leung, Joel S. Freundlich, and William R. Jacobs. "Enhanced respiration prevents drug tolerance and drug resistance in Mycobacterium tuberculosis." Proceedings of the National Academy of Sciences 114, no. 17 (April 10, 2017): 4495–500. http://dx.doi.org/10.1073/pnas.1704376114.
Повний текст джерелаLim, Juhyeon, Jae Jin Lee, Sun-Kyung Lee, Seoyong Kim, Seok-Yong Eum, and Hyungjin Eoh. "Phosphoenolpyruvate depletion mediates both growth arrest and drug tolerance of Mycobacterium tuberculosis in hypoxia." Proceedings of the National Academy of Sciences 118, no. 35 (August 23, 2021): e2105800118. http://dx.doi.org/10.1073/pnas.2105800118.
Повний текст джерелаLiu, Yancheng, Shumin Tan, Lu Huang, Robert B. Abramovitch, Kyle H. Rohde, Matthew D. Zimmerman, Chao Chen, Véronique Dartois, Brian C. VanderVen, and David G. Russell. "Immune activation of the host cell induces drug tolerance in Mycobacterium tuberculosis both in vitro and in vivo." Journal of Experimental Medicine 213, no. 5 (April 25, 2016): 809–25. http://dx.doi.org/10.1084/jem.20151248.
Повний текст джерелаFattorini, Lanfranco, Giovanni Piccaro, Alessandro Mustazzolu, and Federico Giannoni. "TARGETING DORMANT BACILLI TO FIGHT TUBERCULOSIS." Mediterranean Journal of Hematology and Infectious Diseases 5, no. 1 (November 19, 2013): e2013072. http://dx.doi.org/10.4084/mjhid.2013.072.
Повний текст джерелаSaito, Kohta, Thulasi Warrier, Selin Somersan-Karakaya, Lina Kaminski, Jianjie Mi, Xiuju Jiang, Suna Park, et al. "Rifamycin action on RNA polymerase in antibiotic-tolerant Mycobacterium tuberculosis results in differentially detectable populations." Proceedings of the National Academy of Sciences 114, no. 24 (May 30, 2017): E4832—E4840. http://dx.doi.org/10.1073/pnas.1705385114.
Повний текст джерелаGenestet, Charlotte, Elisabeth Hodille, Alexia Barbry, Jean-Luc Berland, Jonathan Hoffmann, Emilie Westeel, Fabiola Bastian, et al. "Rifampicin exposure reveals within-host Mycobacterium tuberculosis diversity in patients with delayed culture conversion." PLOS Pathogens 17, no. 6 (June 24, 2021): e1009643. http://dx.doi.org/10.1371/journal.ppat.1009643.
Повний текст джерелаIacobino, Angelo, Lanfranco Fattorini, and Federico Giannoni. "Drug-Resistant Tuberculosis 2020: Where We Stand." Applied Sciences 10, no. 6 (March 22, 2020): 2153. http://dx.doi.org/10.3390/app10062153.
Повний текст джерелаYadav, Pramod. "Challenges & Solutions for Recent Advancements in Multi-Drugs Resistance Tuberculosis: A Review." Microbiology Insights 16 (January 2023): 117863612311524. http://dx.doi.org/10.1177/11786361231152438.
Повний текст джерелаChoudhury, Sreetama, Ajay Suresh Akhade, and Naeha Subramanian. "Dual RNA-seq as an effective tool to simultaneously identify transcriptional changes in host macrophages and invading intracellular pathogens." Journal of Immunology 204, no. 1_Supplement (May 1, 2020): 227.27. http://dx.doi.org/10.4049/jimmunol.204.supp.227.27.
Повний текст джерелаIvanenko, N. "BIOFILM AND TUMOR: INTERPRETATION OF INTERACTION AND TREATMENT STRATEGIES. Review." Medical Science of Ukraine (MSU) 17, no. 1 (March 30, 2021): 104–20. http://dx.doi.org/10.32345/2664-4738.1.2021.13.
Повний текст джерелаLin, Haifeng, Jie Ma, Manyun Zhuo, Chengsheng Zhang, Jingru Luo, Xiaohong Zhuang, Zhiming Zeng, and Lihua Yang. "Preliminary results of the phase II ALTER-H003 trial: Anlotinib plus toripalimab as a first-line treatment for patients with unresectable hepatocellular carcinoma." Journal of Clinical Oncology 39, no. 3_suppl (January 20, 2021): 314. http://dx.doi.org/10.1200/jco.2021.39.3_suppl.314.
Повний текст джерелаSamuels, Amanda N., Erin R. Wang, Gregory A. Harrison, Joy C. Valenta, and Christina L. Stallings. "Understanding the contribution of metabolism to Mycobacterium tuberculosis drug tolerance." Frontiers in Cellular and Infection Microbiology 12 (August 22, 2022). http://dx.doi.org/10.3389/fcimb.2022.958555.
Повний текст джерелаKreutzfeldt, Kaj M., Robert S. Jansen, Travis E. Hartman, Alexandre Gouzy, Ruojun Wang, Inna V. Krieger, Matthew D. Zimmerman, et al. "CinA mediates multidrug tolerance in Mycobacterium tuberculosis." Nature Communications 13, no. 1 (April 22, 2022). http://dx.doi.org/10.1038/s41467-022-29832-1.
Повний текст джерелаEoh, Hyungjin, Rachel Liu, Juhyeon Lim, Jae Jin Lee, and Philip Sell. "Central carbon metabolism remodeling as a mechanism to develop drug tolerance and drug resistance in Mycobacterium tuberculosis." Frontiers in Cellular and Infection Microbiology 12 (August 22, 2022). http://dx.doi.org/10.3389/fcimb.2022.958240.
Повний текст джерелаSarathy, Jansy P., Min Xie, Richard M. Jones, Adrienne Chang, Paulina Osiecki, Danielle Weiner, Wen-Shan Tsao, et al. "A Novel Tool to Identify Bactericidal Compounds against Vulnerable Targets in Drug-Tolerant M. tuberculosis found in Caseum." mBio, April 5, 2023. http://dx.doi.org/10.1128/mbio.00598-23.
Повний текст джерелаShankaran, Deepthi, Anjali Singh, Stanzin Dawa, Prabhakar Arumugam, Sheetal Gandotra, and Vivek Rao. "The antidepressant sertraline provides a novel host directed therapy module for augmenting TB therapy." eLife 12 (January 11, 2023). http://dx.doi.org/10.7554/elife.64834.
Повний текст джерелаKhan, Mehak Zahoor, and Vinay Kumar Nandicoori. "Deletion of pknG Abates Reactivation of Latent Mycobacterium tuberculosis in Mice." Antimicrobial Agents and Chemotherapy 65, no. 4 (March 18, 2021). http://dx.doi.org/10.1128/aac.02095-20.
Повний текст джерелаImmanuel, Selva Rupa Christinal, Mario L. Arrieta-Ortiz, Rene A. Ruiz, Min Pan, Adrian Lopez Garcia de Lomana, Eliza J. R. Peterson, and Nitin S. Baliga. "Quantitative prediction of conditional vulnerabilities in regulatory and metabolic networks using PRIME." npj Systems Biology and Applications 7, no. 1 (December 2021). http://dx.doi.org/10.1038/s41540-021-00205-6.
Повний текст джерелаTükenmez, Hasan, Souvik Sarkar, Saber Anoosheh, Anastasiia Kruchanova, Isabel Edström, Gregory A. Harrison, Christina L. Stallings, Fredrik Almqvist, and Christer Larsson. "Mycobacterium tuberculosis Rv3160c is a TetR-like transcriptional repressor that regulates expression of the putative oxygenase Rv3161c." Scientific Reports 11, no. 1 (January 15, 2021). http://dx.doi.org/10.1038/s41598-021-81104-y.
Повний текст джерелаDe Siena, Barbara, Nicoletta Campolattano, Gianluca D’Abrosca, Luigi Russo, Daire Cantillon, Rosangela Marasco, Lidia Muscariello, Simon J. Waddell, and Margherita Sacco. "Characterization of the Mycobacterial MSMEG-3762/63 Efflux Pump in Mycobacterium smegmatis Drug Efflux." Frontiers in Microbiology 11 (December 3, 2020). http://dx.doi.org/10.3389/fmicb.2020.575828.
Повний текст джерелаSrinivas, Vivek, Mario L. Arrieta-Ortiz, Amardeep Kaur, Eliza J. R. Peterson, and Nitin S. Baliga. "PerSort Facilitates Characterization and Elimination of Persister Subpopulation in Mycobacteria." mSystems 5, no. 6 (December 1, 2020). http://dx.doi.org/10.1128/msystems.01127-20.
Повний текст джерелаMitini-Nkhoma, Steven C., Elizabeth T. Chimbayo, David T. Mzinza, David V. Mhango, Aaron P. Chirambo, Christine Mandalasi, Agness E. Lakudzala, Dumizulu L. Tembo, Kondwani C. Jambo, and Henry C. Mwandumba. "Something Old, Something New: Ion Channel Blockers as Potential Anti-Tuberculosis Agents." Frontiers in Immunology 12 (June 24, 2021). http://dx.doi.org/10.3389/fimmu.2021.665785.
Повний текст джерелаMavi, Parminder Singh, Shweta Singh, and Ashwani Kumar. "Media component bovine serum albumin facilitates the formation of mycobacterial biofilms in response to reductive stress." BMC Microbiology 23, no. 1 (April 20, 2023). http://dx.doi.org/10.1186/s12866-023-02853-6.
Повний текст джерелаYamamoto, Kentaro, Noboru Nakata, Tetsu Mukai, Ikuro Kawagishi, and Manabu Ato. "Coexpression of MmpS5 and MmpL5 Contributes to Both Efflux Transporter MmpL5 Trimerization and Drug Resistance in Mycobacterium tuberculosis." mSphere 6, no. 1 (January 6, 2021). http://dx.doi.org/10.1128/msphere.00518-20.
Повний текст джерелаHasenoehrl, Erik J., Thomas J. Wiggins, and Michael Berney. "Bioenergetic Inhibitors: Antibiotic Efficacy and Mechanisms of Action in Mycobacterium tuberculosis." Frontiers in Cellular and Infection Microbiology 10 (January 11, 2021). http://dx.doi.org/10.3389/fcimb.2020.611683.
Повний текст джерелаGoyal, Akanksha, Maria Hauswald, Helen McCallum, Gerald Hoebarth, and Annette Feussner. "Fit-for-purpose validation of a drug-tolerant immunogenicity assay for a human mAb drug in animal safety studies." Journal of Immunological Methods, December 2022, 113406. http://dx.doi.org/10.1016/j.jim.2022.113406.
Повний текст джерелаKilany, Lobna Abdel Aziz, Ayman Abdel Samie Gaber, Mohammad Mabrouk Aboulwafa, and Hamdallah Hafez Zedan. "Trastuzumab immunogenicity development in patients’ sera and in laboratory animals." BMC Immunology 22, no. 1 (February 19, 2021). http://dx.doi.org/10.1186/s12865-021-00405-z.
Повний текст джерела